JP Morgan Initiates Coverage On Organon with Neutral Rating, Announces Price Target of $38
JP Morgan analyst Chris Schott initiates coverage on Organon (NYSE:OGN) with a Neutral rating and announces Price Target of $38.
Cantor Fitzgerald Initiates Coverage On ADC Therapeutics with Overweight Rating, Announces Price Target of $46
Cantor Fitzgerald analyst Brian Cheng initiates coverage on ADC Therapeutics (NYSE:ADCT) with a Overweight rating and announces Price Target of $46.
Jefferies Initiates Coverage On Dentalcorp Holdings with Buy Rating, Announces Price Target of C$17
Jefferies analyst Stephanie Wissink initiates coverage on Dentalcorp Holdings (TSX:DNTL) with a Buy rating and announces Price Target of C$17.
Barrington Research Initiates Coverage On Concentrix with Outperform Rating, Announces Price Target of $182
Barrington Research analyst Vincent Colicchio initiates coverage on Concentrix (NASDAQ:CNXC) with a Outperform rating and announces Price Target of $182.
Roth Capital Initiates Coverage On Field Trip Health with Buy Rating, Announces Price Target of C$18
Roth Capital analyst Elemer Piros initiates coverage on Field Trip Health (TSX:FTRP) with a Buy rating and announces Price Target of C$18.
Raymond James Initiates Coverage On Myriad Genetics with Market Perform Rating
Raymond James analyst Andrew Cooper initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Market Perform rating.
Raymond James Initiates Coverage On Guardant Health with Market Perform Rating
Raymond James analyst Andrew Cooper initiates coverage on Guardant Health (NASDAQ:GH) with a Market Perform rating.
Raymond James Initiates Coverage On Natera with Market Perform Rating
Raymond James analyst Andrew Cooper initiates coverage on Natera (NASDAQ:NTRA) with a Market Perform rating.
BTIG Initiates Coverage On Mogo with Buy Rating, Announces Price Target of $13
BTIG analyst Mark Palmer initiates coverage on Mogo (NASDAQ:MOGO) with a Buy rating and announces Price Target of $13.